<DOC>
	<DOCNO>NCT01397448</DOCNO>
	<brief_summary>The primary objective study evaluate effect prevent recurrence gastric duodenal ulcer administer E3810 5 mg 10 mg tablet daily Teprenone 150 mg/day ( 50 mg three time daily ) control patient receive low-dose aspirin thereby examine superiority E3810 Teprenone .</brief_summary>
	<brief_title>Prevention Recurrent Gastric Duodenal Ulcers Caused Low-dose Aspirin With Rabeprazole ( E3810 ) Treatment ( Planetarium Study )</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Duodenal Ulcer</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Geranylgeranylacetone</mesh_term>
	<criteria>Inclusion Criteria Require longterm administration lowdose aspirin ( 81 mg/day 100 mg/day ) Confirmed history gastric duodenal ulcer Exclusion Criteria Confirmed acute gastro duodenal mucosal lesion , gastric duodenal ulcer , upper gastrointestinal ( esophagus , stomach , duodenum ) bleeding Confirmed reflux esophagitis long segment Barrett 's esophagus</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Rabeprazole</keyword>
	<keyword>proton pump inhibitor</keyword>
	<keyword>Acetylsalicylic Acid</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Gastric Ulcer</keyword>
	<keyword>Duodenal Ulcer</keyword>
</DOC>